Last updated on October 17, 2018
A panel of immunotherapy experts discusses the latest cancer immunotherapy advances featured at the world’s largest oncology conference—the 2018 annual meeting of the American Society of Clinical Oncology (ASCO)—with topics including combination immunotherapy, biomarker development, CAR T cell therapies,
and new approaches to immune-based cancer treatment. Panelists include: Charles G. Drake, M.D., Ph.D., of NewYork-Presbyterian/Columbia University Medical Center,
and Catherine Diefenbach, M.D., and Jeffrey S. Weber, M.D., of the Perlmutter Cancer Center at NYU Langone Health. Jill O’Donnell-Tormey, Ph.D., of the Cancer Research
Institute, moderates. We present this video as part of the Answer to Cancer patient and caregiver education program of the Cancer Research Institute, and feature
it as part of our sixth annual global awareness campaign, Cancer Immunotherapy Month, in June.
Be First to Comment